Subsequent Events	3 Months Ended
Mar. 31, 2023
Subsequent Events [Abstract]
Subsequent Events	18. Subsequent Events The Company evaluates subsequent events and transactions that occur after the balance sheet date up to the date that the financial statements were issued. Other than as described below, and except for the effects of the restatement as discussed in Note 2 to the consolidated financial statements, the Company did not identify subsequent events that would have required adjustment or disclosure in the consolidated financial statements. On April 10, 2023, the Company’s Board of Directors adopted the 2023 Omnibus Incentive Plan (the “2023 Plan”), subject to the approval of our stockholders, which was obtained at the Company’s annual meeting of stockholders held on May 9, 2023. The 2023 Plan authorizes a total of 2,700,000 shares to be issued pursuant to awards and will also replace the Company’s predecessor plan (the 2021 Plan) such that shares available for grant under the 2021 Plan would instead be available for grant under the 2023 Plan. Upon approval of the 2023 Plan, the sign-on RSUs previously disclosed for Messrs. Weil and Pierce as part of amendments to their employment contracts in January 2023 were effective (comprising an aggregate of 250,000 performance-based RSUs and 125,000 stock price-based RSUs).

Subsequent Events

3 Months Ended

Mar. 31, 2023

18. Subsequent Events

The Company evaluates subsequent events and transactions that occur after the balance sheet date up to the date that the financial statements were issued. Other than as described below, and except for the effects of the restatement as discussed in Note 2 to the consolidated financial statements, the Company did not identify subsequent events that would have required adjustment or disclosure in the consolidated financial statements.

On April 10, 2023, the Company’s Board of Directors adopted the 2023 Omnibus Incentive Plan (the “2023 Plan”), subject to the approval of our stockholders, which was obtained at the Company’s annual meeting of stockholders held on May 9, 2023. The 2023 Plan authorizes a total of 2,700,000 shares to be issued pursuant to awards and will also replace the Company’s predecessor plan (the 2021 Plan) such that shares available for grant under the 2021 Plan would instead be available for grant under the 2023 Plan. Upon approval of the 2023 Plan, the sign-on RSUs previously disclosed for Messrs. Weil and Pierce as part of amendments to their employment contracts in January 2023 were effective (comprising an aggregate of 250,000 performance-based RSUs and 125,000 stock price-based RSUs).